News for ZIVO Bioscience, Inc. (ZIVO)

ZIVO Bioscience (ZIVO) partners with a leading global animal health company to advance immune-boosting compounds for poultry. The collaboration includes

ZIVO Bioscience, Inc. (ZIVO) partners with the University of Delaware to test formulations for mitigating Avian Influenza in poultry. Promising results

Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed

Zivo Bioscience director Laith Yaldoo acquires $49,993 in stock

John Payne, President and Chief Executive Officer of Zivo Bioscience Inc (ZIVO), purchased 6,343 shares of the company on October 16, 2024, according to a recen

On August 22, 2024, Christopher Maggiore, serving as Director and 10% Owner, purchased 31,336 shares of Zivo Bioscience Inc (ZIVO) as reported in a recent SEC F

ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens

Zivo Bioscience director buys $16.7k in company stock

NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group N.V.'s securities were suspended on July 21, 2023, and have not

NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common shares of Sono Group N.V. Sono Group...

Zivo reports breakthrough in poultry feed efficiency

Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces it has...

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.